36Kr learned that Wanchen Biotechnology released its third-quarter financial report. The report shows that in the third quarter, the company achieved operating revenue of 13.98 billion yuan, a year-on-year increase of 44.15%; the net profit attributable to shareholders of the listed company was 383 million yuan, a year-on-year increase of 361.22%; basic earnings per share were 2.0436 yuan
